Stocks trending after hours: Levi Strauss, AMD, Tilray, and more

S&P 500




Dow 30








Russell 2000




Crude Oil
















10-Yr Bond
















CMC Crypto 200




FTSE 100




Nikkei 225




Levi Strauss (LEVI): Shares fell 5% in extended trading after the jeans-maker lowered its full year forecast, citing the strong dollar and supply chain disruptions. Levi sees full-year adjusted earnings per share of $1.44 to $1.49, down from its previous range of $1.50 to $1.56, and 2022 net revenue growth of 6.7% to 7%.

For the third quarter, Levi reported adjusted earnings of 40 cents a share on revenue of $1.52 billion.

Advanced Micro Devices (AMD): The chipmaker fell in after hours trading after the company lowered its guidance for third-quarter venue, noting a weak PC market and “significant” inventory corrections throughout the PC supply chain. AMD now sees 3Q sales of $5.6 billion, down from its previous estimate of $6.71 billion.

Competitors Nvidia (NVDA) and Intel (INTC) fell in the post market on the news.

Tilray (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB): Cannabis stocks soared ahead of the close and added to gains in extended trading after President Biden pardoned all prior Federal offenses of simple possession of marijuana. Biden also urged Governors to do the same with state offenses and asked the Secretary of Health and Human Services Xavier Becerra and Attorney General Merrick Garland to review how marijuana is classified under federal law.

Click here for the latest trending stock tickers of the Yahoo Finance platform

Click here for the latest stock market news and in-depth analysis, including events that move stocks

Read the latest financial and business news from Yahoo Finance

Download the Yahoo Finance app for Apple or Android

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube


UK businesses most downbeat about profits since Q4 2020 – BCC

British companies are the most downbeat about the outlook for their profits since the depths of the COVID-19 pandemic in late 2020 despite widespread plans to raise prices, a major survey showed on Thursday, adding to signs of gloom about the economy. Only one in three businesses are confident their profits will increase in the coming year, while 39% expect a decline, according to the British Chambers of Commerce’s (BCC) quarterly survey, the largest of its kind. Concerns that soaring inflation will become entrenched have spurred the Bank of England to hike interest rates.

CNW Group

The Valens Company to Release Financial Results for the Third Quarter of 2022

The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the “Company” “The Valens Company” or “Valens”) a leading manufacturer of cannabis products, is pleased to announce it will issue its third quarter 2022 financial results for the period ended August 31, 2022, on Thursday, October 13, 2022, before market open.


Investing Pros Point to These Barriers When Implementing ESG Policies

Investments that weigh environmental, social and governance (ESG) factors have a material impact on the investment policies of a group of recently surveyed asset owners. But hurdles remain on the road toward implementing ESG policies, respondents say in the multipart … Continue reading → The post Investing Pros Point to These Barriers When Implementing ESG Policies appeared first on SmartAsset Blog.

AMD’s Revenue Misses by a Mile. The Stock Is Falling.

The chip maker warned that revenue for the third quarter would be lower than expected. CEO Lisa Su said that the PC market has “weakened significantly.”

Motley Fool

What the Smartest Investors Know About Carnival Stock

Cruise line Carnival (NYSE: CCL) has become a popular comeback story on Wall Street. COVID-19 did a lot of damage to tourism-focused companies like Carnival, which are just now getting their sea legs back under them. Carnival could hit the high seas at full capacity over the next several years.

Motley Fool

Why Agenus Stock Rose 18.4% on Thursday

Shares of Agenus (NASDAQ: AGEN), a clinical-stage biopharmaceutical company that specializes in immuno-oncology, saw its shares jump 18.4% on Thursday. First, the company on Wednesday said it planned to present data on botensilimab, a therapy that is being studied for its effectiveness as a combination drug or a monotherapy to active T-cell immune responses in patients who have pancreatic cancer, colorectal cancer, or melanoma, a type of skin cancer. Another move that helped push up the stock was the announcement of inside buying of Agenus stock by some members of the company’s board of directors on Wednesday, including Susan Hirsch, Wadih Jordan, Ulf Wiinberg, and Timothy Wright, totaling more than 30,000 Agenus shares.

Motley Fool

Why Ford, Tesla, and Nio Stocks Fell Today

Tic-tac-toe, three in a row, shares of Ford Motor Company (NYSE: F), Tesla (NASDAQ: TSLA), and Nio (NYSE: NIO) are down 2%, 1.9%, and 5.9%, respectively. In the case of electric vehicle (EV) specialists Tesla and Nio, it’s basically Wall Street to blame for today’s declines. Granted, yesterday’s announcement that Elon Musk has apparently decided he will buy Twitter after all is probably still having an effect on Tesla stock — but there’s new news, too.

Insider Monkey

15 Best Short Squeeze Stocks to Buy Now

In this article, we discuss 15 best short squeeze stocks to buy now. If you want to see more stocks like these, check out 5 Best Short Squeeze Stocks to Buy Now. In 2021, retail trading activity resulted in an unparalleled short squeeze that led major capital market players to lose billions of dollars. In […]

Motley Fool

These 3 Oil Stocks Are Wildly Undervalued as Crude Surges Toward $90 a Barrel

Oil prices have been all over the place this year. WTI, the primary U.S. oil price benchmark, started 2022 at around $75 a barrel before rocketing over $120 a barrel following Russia’s invasion of Ukraine. The move could keep a floor under crude prices and potentially push them higher depending on demand and other supplies.


The Zacks Analyst Blog Highlights Shell, Chevron, Cheniere Energy, Kinder Morgan and Energy Transfer LP

Shell, Chevron, Cheniere Energy, Kinder Morgan and Energy Transfer LP are part of the Zacks top Analyst Blog.

Leave a Reply

Your email address will not be published. Required fields are marked *